Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2021, Vol. 41 Issue (10): 127-131    DOI: 10.13523/j.cb.2108028
    
Policy Research on the Construction of Biotechnology Base Platforms in China
WU Han-rong,WANG Ying,LI Su-ning,SANG Xiao-dong,FAN Ling()
China National Center for Biotechnology Development, Beijing 100039, China
Download: HTML   PDF(453KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Biotechnology base platforms are important foundation for biotechnology research, production and services, and meanwhile, policies related to biotechnology base platforms play an important role in guiding and promoting the development of biotechnology base platforms in China. This article takes the biotechnology base platform policies formulated by the Central Committee of the Communist Party of China, the State Council and the Ministry of Science and Technology and other government sectors in the past ten years as study object. Through textual analysis, this article summarizes the value connotation of China’s biotechnology base platform policies, and discusses the construction law, so as to provide reference for the innovation and development of the base platform.



Key wordsBiotechnology      Base platform construction      Policy research     
Received: 11 August 2021      Published: 08 November 2021
ZTFLH:  Q819  
Corresponding Authors: Ling FAN     E-mail: fanling@cncbd.org.cn
Cite this article:

WU Han-rong,WANG Ying,LI Su-ning,SANG Xiao-dong,FAN Ling. Policy Research on the Construction of Biotechnology Base Platforms in China. China Biotechnology, 2021, 41(10): 127-131.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.2108028     OR     https://manu60.magtech.com.cn/biotech/Y2021/V41/I10/127

序号 发文年份 发文主体 政策名称
1 2011 科技部 国家“十二五”科学和技术发展规划
2 2011 科技部 “十二五”生物技术发展规划
3 2012 国务院 生物产业发展规划
4 2012 国家中医药管理局 中医药文化建设“十二五”规划
5 2014 科技部、国家卫生计生委、总后勤部卫生部 国家临床医学研究中心管理办法(试行)
6 2014 科技部 国家重点实验室评估规则
7 2016 中共中央、国务院 “健康中国2030”规划纲要
8 2016 国务院 “十三五”国家科技创新规划
9 2016 国务院 国家创新驱动发展战略纲要
10 2016 国务院 “十三五”国家战略性新兴产业发展规划
11 2016 国务院办公厅 国务院办公厅关于促进医药产业健康发展的指导意见
12 2016 工业和信息化部、发改委、科技部等六部委 医药工业发展规划指南
13 2017 发改委 “十三五”生物产业发展规划
14 2017 科技部 国家技术创新中心建设工作指引
15 2017 科技部、财政部、发改委 “十三五”国家科技创新基地与条件保障能力建设专项规划
16 2017 科技部、财政部、发改委 国家科技创新基地优化整合方案
17 2017 科技部 “十三五”生物技术创新专项规划
18 2017 科技部 国家临床医学研究中心运行绩效评估方案(试行)
19 2017 科技部 生物技术研究开发安全管理办法
20 2017 科技部、国家卫生计生委、总后勤部卫生部 国家临床医学研究中心管理办法(试行)(2017年修订)
21 2018 国务院 关于全面加强基础科学研究的若干意见
22 2018 国务院办公厅 科学数据管理办法
23 2018 发改委 关于组织实施生物医药合同研发和生产服务平台建设专项的通知
24 2018 科技部,财政部 国家科技资源共享服务平台管理办法
25 2018 科技部、财政部等六部委 新形势下加强基础研究若干重点举措
26 2018 科技部 国家野外科学观测研究站管理办法
27 2018 科技部、发改委和财政部 国家重大科研基础设施和大型科研仪器开放共享管理办法
28 2018 科技部、国家卫生计生委等 国家临床医学研究中心五年(2017-2021)发展规划
29 2019 中共中央、国务院 中共中央国务院关于促进中医药传承创新发展的意见
30 2019 科技部 关于促进新型研发机构发展的指导意见
31 2019 科技部、财政部 国家野外科学观测研究站建设发展方案(2019-2025)
32 2019 科技部、海南省 加快海南科技创新开放发展实施方案
33 2020 国务院 国务院关于促进国家高新技术产业开发区高质量发展的若干意见
34 2020 发改委 国家工程研究中心管理办法
35 2020 发改委、卫健委、国家中医药管理局 公共卫生防控救治能力建设方案
36 2020 科技部 科技部办公厅关于加快推动国家科技成果转移转化示范区建设发展的通知
37 2020 科技部、发改委、教育部、中科院、自科基金委 加强“从0到1”基础研究工作方案
38 2020 科技部 关于推进国家技术创新中心建设的总体方案(暂行)
39 2020 科技部 长三角科技创新共同体建设发展规划
40 2021 科技部 国家高新区绿色发展专项行动实施方案
Table 1 Important guiding policies for the construction of biotechnology base platforms in China
Fig.1 Time distribution of policies for the construction of biotechnology base platforms from 2011~2020
[1]   中华人民共和国中央人民政府. 中华人民共和国国民经济和社会发展第十四个五年规划和2035年远景目标纲要. [2021-03-11]. http://www.gov.cn/xinwen/2021-03/13/content_5592681.htm.
[1]   The Central People’s Government of the People’s Republic of China. Outline of the 14th five-year plan (2021-2025) for national economic and social development and the long-range objectives through the year 2035. [2021-03-11]. http://www.gov.cn/xinwen/2021-03/13/content_5592681.htm.
[2]   科学技术部. “十三五”国家科技创新基地与条件保障能力建设专项规划. [2017-10-24]. http://www.most.gov.cn/xxgk/xinxifenlei/fdzdgknr/fgzc/gfxwj/gfxwj2017/201710/t20171026_135754.html.
[2]   Ministry of Science and Technology. The 13th five-year plan for the construction of national science and technology innovation base and condition guarantee capacity. [2017-10-24]. http://www.most.gov.cn/xxgk/xinxifenlei/fdzdgknr/fgzc/gfxwj/gfxwj2017/201710/t20171026_135754.html.
[3]   习近平. 在中国科学院第二十次院士大会、中国工程院第十五次院士大会、中国科协第十次全国代表大会上的讲话. [2021-05-28]. http://news.cnr.cn/native/gd/20210528/t20210528_525498856.shtml.
[3]   Xi J P. Speech at the 20th academician conference of the chinese academy of sciences, the 15th academician conference of the chinese academy of engineering and the 10th national congress of the China association for science and technology. [2021-05-28]. http://news.cnr.cn/native/gd/20210528/t20210528_525498856.shtml.
[4]   科学技术部, 财政部, 国家发展和改革委员会. 国家科技创新基地优化整合方案. [2017-08-25]. http://www.most.gov.cn/tztg/201708/t20170825_134601.htm.
[4]   Ministry of Science and Technology, Ministry of Finance, National Developmet and Reform Commission. Optimization and integration plan of national science and technology innovation base. [2017-08-25]. http://www.most.gov.cn/tztg/201708/t20170825_134601.htm.
[5]   国家发展和改革委员会. “十三五”生物产业发展规划.[2016-12-20]. https://www.ndrc.gov.cn/xxgk/zcfb/ghwb/201701/t20170112_962220.html.
[5]   National Development and Reform Commission. The 13th five-year plan for bioindustry development.[2016-12-20]. https://www.ndrc.gov.cn/xxgk/zcfb/ghwb/201701/t20170112_962220.html.
[6]   科学技术部. “十二五”生物技术发展规划. [2011-11-28]. http://www.most.gov.cn/fggw/zfwj/zfwj2011/201111/t20111128_91115.htm.
[6]   Ministry of Science and Technology. The 12th five-year plan for biotechnology development. [2011-11-28]. http://www.most.gov.cn/fggw/zfwj/zfwj2011/201111/t20111128_91115.htm.
[7]   科学技术部. 关于促进新型研发机构发展的指导意见. [2019-09-12]. http://www.most.gov.cn/xxgk/xinxifenlei/fdzdgknr/fgzc/gfxwj/gfxwj2019/201909/t20190917_148802.html.
[7]   Ministry of Science and Technology. Guidelines on promoting the development of new research and development organization. [2019-09-12]. http://www.most.gov.cn/xxgk/xinxifenlei/fdzdgknr/fgzc/gfxwj/gfxwj2019/201909/t20190917_148802.html.
[8]   国家发展和改革委员会, 工业和信息化部, 国家卫生健康委员会, 国家药品监督管理局. 关于组织实施生物医药合同研发和生产服务平台建设专项的通知. [2018-05-13]. http://health.people.com.cn/n1/2018/0626/c14739-30086188.html.
[8]   National Development and Reform Commission, Ministry of Industry and Information Technology, National Health Commission, National Medical Products Administration. Notice on organizing and implementing the construction of biomedical contract research and development and production service platform.[2018-05-13]. http://health.people.com.cn/n1/2018/0626/c14739-30086188.html.
[1] LIU Xu-xia,YANG An-ke. An Analysis of the U.S. SECURE Rule and Its Enlightenment to China[J]. China Biotechnology, 2021, 41(9): 126-135.
[2] HU Yuan-lei,CHEN Yan-cheng,PU Run,YAO Wei-hao,ZHANG Hong-xiang. Bio-tech Startup Incubation Best Practice in the United Kingdom and Suggestion[J]. China Biotechnology, 2021, 41(4): 100-105.
[3] WU Han-rong,WANG Ying,HUANG Ying-ming,LI Dong-xue,LI Zhi-fei,FANG Zi-han,FAN Lin. Promote the Innovation and Transformation of Biotechnology by Base Platform[J]. China Biotechnology, 2021, 41(12): 141-147.
[4] WU Han-rong,WANG Ying,YANG Li,GE Yao,FAN Ling. Current Situation and Development Suggestions of China’s Biotechnology Base Platform[J]. China Biotechnology, 2021, 41(11): 119-123.
[5] WANG Xiao-li. The Age of Biosecurity: New Biotechnology Revolution and National Biosecurity Governance[J]. China Biotechnology, 2020, 40(9): 95-109.
[6] SONG Yi-mei,JIA Xiu-wei,LI Shu-biao,GAO Cui-juan. Industrial Microorganism of Yarrowia lipolytica and Its Industrial Amplicaiton[J]. China Biotechnology, 2020, 40(9): 77-86.
[7] HU Yuan-lei,YAO Wei-hao,PU Run,ZHANG Hong-xiang. Bio-tech Startup Incubation Best Practice in the United States[J]. China Biotechnology, 2019, 39(12): 103-109.
[8] Ping ZHAO,Bo ZHANG,Xue-zhao WANG. Patent Situation Analysis in Agricultural Biotechnology Field[J]. China Biotechnology, 2018, 38(8): 100-107.
[9] Fang CHEN,Yun-wei CHEN,Chen-jun DING,Ying ZHENG,Xiao-yan WU,Dan-dan LUO,Qiu-wei ZHAO,Bo YU. A Study on the Trends of Biotechnology Development in Countries along the Belt and Road[J]. China Biotechnology, 2018, 38(1): 1-14.
[10] SHEN Ping, WU Yu-hua, LIANG Jin-gang, LU Xin, ZHANG Qiu-yan, WANG Hao-qian, LIU Peng-cheng. The Overview in Development and Application of Genetically Modifed Crops[J]. China Biotechnology, 2017, 37(1): 119-128.
[11] CHEN Fang, DING Chen-jun, CHEN Yun-wei, ZHENG Ying, DENG Yong, XU Ping, YU Jian-rong, WU Lin-huan, MA Jun-cai, ZENG Yan, LIU Bin. A Study on the Trend and Prospective of Industrial Biotechnology in China[J]. China Biotechnology, 2016, 36(5): 1-11.
[12] LI Geng, LIU Xiao-zhi, WANG Zhi-ming, GAO Jian. Progress in the Application of Non-immunoglobulin Scaffolds[J]. China Biotechnology, 2016, 36(2): 90-95.
[13] WANG Kai, ZHANG Wei, LI Shi-weng. Study and Application of Phytase[J]. China Biotechnology, 2015, 35(9): 85-93.
[14] GAO Jiao-qi, HAN Xi-tong, KONG Liang, YUAN Wen-jie, WANG Na, BAI Feng-wu. Application Progress of Kluyveromyces marxianus in the Industrial Biotechnology[J]. China Biotechnology, 2014, 34(2): 109-117.
[15] WU Xue-mei, QU Kai. Problems and Solutions in the Drafting of Biotechnological Patents[J]. China Biotechnology, 2013, 33(12): 127-132.